ZGJTSXF administration could ameliorate DCM mice by remodeling gut microbiota structure, reducing serum TMAO generation and suppressing TMAO/PERK/FoxO1 signaling pathway. Here, EIF2AK3 is linked to familial dilated cardiomyopathy.